NCT00773032 arm group 8ea9f996fdd639e2d944fa20e6dcaa4c [clinicaltrials_resource:NCT00773032/arm-group/8ea9f996fdd639e2d944fa20e6dcaa4c]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00773032 arm group 8ea9f996fdd639e2d944fa20e6dcaa4c [clinicaltrials_resource:NCT00773032/arm-group/8ea9f996fdd639e2d944fa20e6dcaa4c]
Bio2RDF identifier
NCT00773032/arm-group/8ea9f996fdd639e2d944fa20e6dcaa4c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a9f996fdd639e2d944fa20e6dcaa4c
description [clinicaltrials_vocabulary:description]
2.5g Sodium Oxybate administered during nap
identifier
clinicaltrials_resource:NCT00773032/arm-group/8ea9f996fdd639e2d944fa20e6dcaa4c
title
NCT00773032 arm group 8ea9f996fdd639e2d944fa20e6dcaa4c
@en
type
label
NCT00773032 arm group 8ea9f996 ...... 9f996fdd639e2d944fa20e6dcaa4c]
@en